|By Marketwired .||
|May 6, 2014 07:00 AM EDT||
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/06/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Harold E. "Barry" Selick, Ph.D., Chief Executive Officer of Threshold and Cary L. Queen, Ph.D., President of Galaxy Biotech, have been jointly named as finalists for the European Inventor Award 2014 in the "Non-European Countries" category. Their nomination is in recognition of their work while at Protein Design Labs, Inc. ("PDL") in inventing the humanized monoclonal antibody technology that is embodied in numerous therapeutics such as Avastin® and Herceptin®, as well as Zenapax®, which was the first humanized antibody therapeutic that was approved as a drug by the U.S. Food & Drug Administration (FDA) and which was PDL's first product. Dr. Queen, who led the antibody humanization program, was the co-founder and head of research at PDL while Dr. Selick was a staff scientist working with him at the time. The final award ceremony at which the winners in each of 5 different categories will be announced will take place in Berlin, Germany, on June 17, 2014.
About the European Inventor Award
The European Inventor Award pays tribute to the creativity of inventors the world over, who use their technical, scientific and intellectual skills to make a real contribution to technological progress and economic growth and so improve people's daily lives. Launched by the European Patent Office (EPO) in 2006, the award gives inventors the recognition they deserve, and helps to encourage creativity and innovation. Any member of the public can nominate an inventor for the European Inventor Award. The selection process relies on the hard work of EPO experts and an independent international jury that evaluates innovations not only on their technological originality but also on their economic and social impact.
About Threshold Pharmaceuticals
Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website (www.thresholdpharm.com).
Laura Hansen, Ph.D.
Senior Director, Corporate Communications
E-mail: [email protected]
Jul. 28, 2016 12:00 PM EDT Reads: 1,214
Jul. 28, 2016 11:15 AM EDT Reads: 1,125
Jul. 28, 2016 11:00 AM EDT Reads: 1,111
Jul. 28, 2016 11:00 AM EDT Reads: 1,785
Jul. 28, 2016 11:00 AM EDT Reads: 2,043
Jul. 28, 2016 10:45 AM EDT Reads: 1,264
Jul. 28, 2016 10:45 AM EDT Reads: 564
Jul. 28, 2016 10:41 AM EDT Reads: 238
Jul. 28, 2016 10:30 AM EDT Reads: 782
Jul. 28, 2016 10:15 AM EDT Reads: 500
Jul. 28, 2016 10:00 AM EDT Reads: 272
Jul. 28, 2016 09:30 AM EDT Reads: 1,402
Security, data privacy, reliability, and regulatory compliance are critical factors when evaluating whether to move business applications from in-house, client-hosted environments to a cloud platform. Quality assurance plays a vital role in ensuring that the appropriate level of risk assessment, verification, and validation takes place to ensure business continuity during the migration to a new cloud platform.
Jul. 28, 2016 09:28 AM EDT Reads: 270
It’s 2016: buildings are smart, connected and the IoT is fundamentally altering how control and operating systems work and speak to each other. Platforms across the enterprise are networked via inexpensive sensors to collect massive amounts of data for analytics, information management, and insights that can be used to continuously improve operations. In his session at @ThingsExpo, Brian Chemel, Co-Founder and CTO of Digital Lumens, will explore: The benefits sensor-networked systems bring to ...
Jul. 28, 2016 09:00 AM EDT Reads: 1,607
"We formed Formation several years ago to really address the need for bring complete modernization and software-defined storage to the more classic private cloud marketplace," stated Mark Lewis, Chairman and CEO of Formation Data Systems, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Jul. 28, 2016 08:30 AM EDT Reads: 1,683